Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Portugal
09 août 2022 08h00 HE
|
Alimera Sciences, Inc.
Reimbursement granted with no restrictions to the labelAlimera to begin selling later in Q3 ATLANTA, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global...